Background: The predictive and prognostic role of neuron-specific enolase (NSE) in non-small cell lung cancer (NSCLC) is still under debate. Patients and Methods: To study these aspects, serum NSE was prospectively measured at baseline of first-line chemotherapy treatment and tested for correlation with clinical outcome in 129 advanced NSCLC patients. Results: An objective response was achieved in 27 out of 65 (41.5%) patients with NSE <8.6 ng/ml and in 38 out of 64 (59.4%) patients with NSE ≥8.6 ng/ml (p=0.05). Logistic analysis confirmed the positive association between objective response and NSE values ≥8.6 ng/ml (odds ratio=1.69; 95% confidence interval: 1.09-2.63; p=0.02). Overall median survival was 10.8 months. A statistically significant prognostic effect on survival was found for performance status, stage and response to treatment, but not for baseline NSE value. Conclusion: Based on these data, baseline circulating tumor NSE levels appear to have a weak predictive role, but not a prognostic significance in patients with advanced NSCLC submitted to standard chemotherapy.

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer / Tiseo, M.; Ardizzoni, A.; Cafferata, M. A.; Loprevite, M.; Chiaramondia, M.; Filiberti, R.; Marroni, P.; Grossi, F.; Paganuzzi, M.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 28:1 B(2008), pp. 507-513.

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer

Tiseo M.;
2008-01-01

Abstract

Background: The predictive and prognostic role of neuron-specific enolase (NSE) in non-small cell lung cancer (NSCLC) is still under debate. Patients and Methods: To study these aspects, serum NSE was prospectively measured at baseline of first-line chemotherapy treatment and tested for correlation with clinical outcome in 129 advanced NSCLC patients. Results: An objective response was achieved in 27 out of 65 (41.5%) patients with NSE <8.6 ng/ml and in 38 out of 64 (59.4%) patients with NSE ≥8.6 ng/ml (p=0.05). Logistic analysis confirmed the positive association between objective response and NSE values ≥8.6 ng/ml (odds ratio=1.69; 95% confidence interval: 1.09-2.63; p=0.02). Overall median survival was 10.8 months. A statistically significant prognostic effect on survival was found for performance status, stage and response to treatment, but not for baseline NSE value. Conclusion: Based on these data, baseline circulating tumor NSE levels appear to have a weak predictive role, but not a prognostic significance in patients with advanced NSCLC submitted to standard chemotherapy.
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer / Tiseo, M.; Ardizzoni, A.; Cafferata, M. A.; Loprevite, M.; Chiaramondia, M.; Filiberti, R.; Marroni, P.; Grossi, F.; Paganuzzi, M.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 28:1 B(2008), pp. 507-513.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2862139
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact